BSX — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates BSX as Bearish with 81% confidence in the Healthcare sector.
AI Analysis Summary
Strongly avoid BSX due to extreme leverage, negative price forecast, and deteriorating fundamentals.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade D — 45/100
- Ray Dalio (Macro/Risk Parity): Grade D — 35/100
Consensus: Bearish
Price Intelligence
- Current price: $58.45
- Price target: $54.95 (-6%)
- Risk level: high
- Horizon: short term
Quality Assessment
- Balance sheet: concerning
- Cash flow: poor
- Competitive moat: none
Peer Group Analysis
BSX is in the “Cash Flow Weak” cluster alongside XEL, WRB, WEC, TRGP, SO (43 stocks total). 0 of 43 peers are currently bullish.